https://dasherneuroscience.com/hydra_mou/2026-04-16T13:02:59+08:00https://dasherneuroscience.com/yoda-ky-7829-new-drug-ya-101-granted-us-fda-fast-track-designation-for-the-treatment-of-multiple-system-atrophy/2026-04-14T14:47:12+08:00https://dasherneuroscience.com/yoda-ky-7829-ya-101-receives-orphan-drug-designation-in-japan-following-u-s-fda-fast-track-advancing-global-development-plans/2026-04-14T14:51:13+08:00https://dasherneuroscience.com/yoda-ky-7829-ya-101-granted-orphan-drug-designation-by-the-eu-ema-for-the-treatment-of-multiple-system-atrophy/2026-04-14T14:52:44+08:00https://dasherneuroscience.com/taiwans-first-yoda-ky-7829-ai-developed-drug-prioritized-by-ilct-for-parkinsons-disease-development-signs-mous-with-australia-and-new-zealand-to-expand-clinical-reach/2026-04-16T13:01:04+08:00